Stocks ARHS Financial statements
Financial statementsArhaus, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Arhaus, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 495 | 507 | 797 | 1,229 | 1,288 | 1,271 | 1,379 |
| Cost of revenue | 319 | 308 | 467 | 704 | 747 | 770 | 843 |
| Gross profit | 176 | 200 | 330 | 525 | 540 | 501 | 536 |
| Selling, general and administrative | 146 | 169 | 296 | 340 | 376 | 415 | 447 |
| Operating income | 29.7 | 30.9 | 33.4 | 185 | 164 | 87 | 88.9 |
| Interest expense | 13.4 | 13.1 | 5.43 | 3.39 | |||
| Other non-operating income | 0 | 0 | 0.32 | 1.29 | 1.03 | 0.75 | 0.06 |
| Pre-tax income | 16.2 | 17.8 | 26.8 | 183 | 169 | 90.9 | 92 |
| Income tax | 0.37 | 0.78 | -10.1 | 45.9 | 43.5 | 22.4 | 24.7 |
| Net income to minority interests | 8.32 | 11 | 15.8 | 0 | 0 | ||
| Net income | 7.53 | 6.08 | 21.1 | 137 | 125 | 68.6 | 67.3 |
| EBITDA | 45.6 | 47.8 | 57.3 | 210 | 194 | 126 | 136 |
| EPS, basic | 0.04 | 0.03 | 0.18 | 0.99 | 0.90 | 0.49 | 0.48 |
| EPS, diluted | 0.04 | 0.03 | 0.18 | 0.98 | 0.89 | 0.49 | 0.48 |
| Shares, basic (weighted) | 112 | 112 | 116 | 138 | 139 | 140 | 141 |
| Shares, diluted (weighted) | 112 | 112 | 120 | 140 | 140 | 141 | 141 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 20.1 | 57.1 | 124 | 145 | 223 | 198 | 253 |
| Receivables | 0.6 | 0.23 | 1.73 | 2.39 | 1.25 | 0.66 | |
| Inventory | 108 | 208 | 286 | 254 | 297 | 339 | |
| Other current assets | 20 | 28.5 | 4.49 | 4.75 | 2.79 | 2.99 | |
| Total current assets | 193 | 368 | 461 | 509 | 531 | 621 | |
| Property, plant and equipment | 118 | 180 | 152 | 220 | 283 | 316 | |
| Lease right-of-use assets | 0 | 257 | 302 | 322 | 391 | ||
| Goodwill | 11 | 11 | 11 | 11 | 11 | 11 | |
| Other non-current assets | 1.28 | 0.28 | 2.25 | 4.53 | 2.29 | 2.1 | |
| Total assets | 323 | 587 | 939 | 1,105 | 1,206 | 1,395 | |
| Accounts payable | 29.1 | 51.4 | 62.6 | 63.7 | 68.6 | 78.4 | |
| Deferred revenue | 154 | 265 | 203 | 174 | 221 | 236 | |
| Total current liabilities | 213 | 401 | 376 | 342 | 402 | 453 | |
| Lease liabilities | 0 | 296 | 363 | 403 | 467 | ||
| Other non-current liabilities | 25 | 1.99 | 4.34 | 4.14 | 3.89 | 3.66 | |
| Total liabilities | 357 | 517 | 730 | 765 | 863 | 977 | |
| Paid-in capital | 1.67 | 186 | 190 | 195 | 201 | 208 | |
| Retained earnings | -28.4 | -117 | 20.1 | 145 | 143 | 210 | |
| Shareholders' equity | -33.4 | -34.4 | 69.8 | 210 | 340 | 344 | 418 |
| Minority interests | -7.69 | 0 | |||||
| Total equity | -38 | -34.4 | 69.8 | 210 | 340 | 344 | 418 |
| Total liabilities and equity | 323 | 587 | 939 | 1,105 | 1,206 | 1,395 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | 15.8 | 17 | 36.9 | 137 | 125 | 68.6 | 67.3 |
| Depreciation and amortization | 16 | 17 | 23.9 | 24.9 | 29.4 | 39.1 | 46.8 |
| Stock-based compensation | 0.27 | 0.4 | 6.38 | 4.29 | 7.91 | 7.64 | 9.18 |
| Deferred income tax | 0 | -10.5 | 9.77 | -2.29 | -1.96 | 1.55 | |
| Change in receivables | -0.18 | -0.16 | 0.37 | -1.51 | -0.66 | 1.14 | 0.59 |
| Change in inventory | -7.82 | 2.05 | -100 | -78.1 | 32.1 | -42.7 | -41.8 |
| Change in payables | 2.13 | 1.61 | 14.5 | 10.3 | 1.22 | 5.62 | 9.86 |
| Cash from operations | 20 | 148 | 140 | 77.5 | 169 | 147 | 137 |
| Capital expenditures | -9.88 | -13 | -41.5 | -55.7 | -93.4 | -107 | -77.9 |
| Cash from investing | -9.87 | -13 | -41.5 | -55.7 | -93.1 | -99.5 | -77.8 |
| Share buybacks | 0 | -0.1 | 0 | 0 | |||
| Dividends paid | 0 | 0 | -70.3 | -0.36 | |||
| Cash from financing | -14.3 | -91.3 | -31.5 | -0.18 | -1.8 | -73 | -3.48 |
| Net change in cash | -4.15 | 43.9 | 66.9 | 21.6 | 73.8 | -25.4 | 55.6 |
| Free cash flow | 10.2 | 135 | 98.4 | 21.8 | 75.2 | 39.7 | 59 |
| Interest paid | 11.3 | 9.3 | 5.12 | 5.16 | 5.3 | 4.67 | 5.03 |
| Income taxes paid | 0.54 | 1.3 | 1.4 | 34.9 | 47.1 | 23.8 | 24.5 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 39.7% | Gross profit / revenue. |
| Operating margin | 6.6% | Operating income / revenue. |
| EBITDA margin | 10.1% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 6.9% | Pre-tax income / revenue. |
| Net margin | 4.9% | Net income / revenue. |
| FCF margin | 2.9% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 8.2% | Cash from operations / revenue. |
| Effective tax rate | 28.7% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 16.7% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 4.8% | Net income / average total assets. |
| Return on invested capital (ROIC) | 35.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 33.1% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.8% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 5.3% | Capital expenditures / revenue. |
| D&A / revenue | 3.5% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 8.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 3.9% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 22.1% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 7.0% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 0.7% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 21.9% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 2.2% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -21.6% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 23.5% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 7.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -13.5% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 23.2% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -1.9% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -21.0% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 61.7% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | -2.0% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -21.2% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 74.1% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -7.0% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 20.9% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -1.6% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 48.4% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 39.3% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | -15.3% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 21.7% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 25.9% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 15.6% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 14.1% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 34.0% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 0.5% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 0.4% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 4.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.33x | Current assets / current liabilities. |
| Quick ratio | 0.47x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.47x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 71.4% | Total liabilities / total assets. |
| Working capital | $158.2M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 0.8% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $404.0M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.97x | Revenue / average total assets. |
| Fixed asset turnover | 4.26x | Revenue / average property, plant and equipment. |
| Inventory turnover | 2.40x | Cost of revenue / average inventory. |
| Days inventory | 152 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 5,969x | Revenue / average receivables. |
| Days sales outstanding | 0 days | 365 x average receivables / revenue. |
| Days payables | 31 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 121 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 59.1% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 64.5% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.49 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $9.93 | Revenue / diluted weighted shares. |
| FCF per share | $0.29 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.81 | Cash from operations / diluted weighted shares. |
| Book value per share | $2.93 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $2.85 | Tangible book value / shares outstanding. |
| Cash per share | $1.60 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 71.8% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 121.6% | Dividends paid / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.38B | Share price x shares outstanding. |
| Enterprise value | $1.15B | Market cap + total debt - cash - short-term investments. |
| P/E | 19.9x | Market cap / net income. Only when net income is positive. |
| P/S | 0.98x | Market cap / revenue. |
| P/B | 3.32x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 3.41x | Market cap / tangible book value, when positive. |
| P/FCF | 33.7x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 11.9x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.82x | Enterprise value / revenue. |
| EV/EBIT | 12.4x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 8.10x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 28.1x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 3.0% | Free cash flow / market cap. |
| Earnings yield | 5.0% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 3.6% | Dividends paid over the period / market cap. |
| Shareholder yield | 3.6% | (Dividends paid + share buybacks) / market cap. |
What was Arhaus, Inc.'s revenue in fiscal 2025?
Arhaus, Inc. reported revenue of $1.38B for fiscal 2025, 8.5% higher than the year before.
Was Arhaus, Inc. profitable in fiscal 2025?
Yes. Net income was $67.3M, a net margin of 4.9%.
How much free cash flow did Arhaus, Inc. generate in fiscal 2025?
Cash from operations of $136.8M minus capital expenditures of $77.9M left free cash flow of $59.0M.